ACNP 64th Annual Meeting: Keyword Index

Key Word Submission Number(s)

(2R,6R)-hydroxynorketamine P189, P264, P609

(R,S)-ketamine P121, P230, P267, P533

[11C]CPPC 15.1

[18F] FEPPA P253

17-β-estradiol P4

1H MRS P328, P330, P456

1H-MRS P754

22q11 deletion syndrome 46, 46.2, 46.5, P458

22q11.2 deletion syndrome 46.3

31P Magnetic Resonance Spectroscopy P527

3D genome P871

5-HT2 Receptors P359

5-HT2A Agonist P627

5-HT2A receptor 45.4, P655, P664

5HT4R agonist P64

5-MeO-DMT P163, P666, P675

7 Tesla fMRI 31.4

7-hydroxymitragynine P321

7q11.23 copy number variation P488

ABCD P6

ABCD study P12, P13, P170, P516, P793

abstinence 26.4, P698

abstraction P184

academic performance P281

Accelerated intermittent theta burst stimulation (iTBS) P233, P572, P581

Accelerated iTBS 27, P576

acetylcholine P353, P479, P453, P637

Across Species 24

Actigraphy P117

actin remodeling P364

Action-outcome associations P738

activated microglia 29.2

Active Avoidance P206

Acute agitation P148

Acute and Chronic Stress P192, P307, P358, P843

Acute effects P642

Acute Stress P97, P202, P293, P510, P764, P834, P837, P842

Acute Traumatic Stress 4.3, P707

Acute treatment 14.4, P412

Adaptive Behavior P65, P145

Adaptive deep brain stimulation P568

Adaptive immunity P91

Adaptive mechanism 48.5

Addiction 10, 19, 30, 11, 11.3, 20, 20.5, P433, P544, P723, P286,

P380, P622

Addiction comorbidity P732

Addiction phenotypes P374, P378, P385, P629

Addiction-like behaviors 30.2, P374, P736

Addictions Neuroclinical Assessment P308

Addictive behavior 43, P330

Addictive screen use P554

Adeno-associated Virus P820

ADHD P115, P169, P170, P171, P490, P522, P576, P610, P816

adjunctive P249

adjunctive treatment P250

Adolescence 3.4, 28.4, P13, P63, P3, P6, P10, P11, P21, P22,

P27, P48, P49, P106, P324, P344, P417, P494, P554,

P576, P669, P824

Adolescence- Critical Period 36.4, P8, P29

Adolescent P5, P60, P154, P409, P852

Adolescent Alcohol P736

Adolescent Anxiety 56.4, 56.5, P8, P417

Adolescent Brain and Cognitive Development Study P539

Adolescent Brain Cognitive Development study 22.1, P1, P493

adolescent cannabis P386

Adolescent Depression 20, 20.2, 22.2, 22.3, 56.4, P2, P8,

P9, P12, P200, P252, P254, P832

adolescent development 22, P7

Adolescent psychiatry P661

Adolescent PTSD 39.3, P10, P695

Adolescent social isolation P435, P831, P840

adolescent stress 48.2, P28, P844

Adolescents P70, P169, P545

adult clincial anxiety P439

adverse childhood experiences (ACE) P539, P646

Adverse drug reaction P430

adverse effects P160

adverse event P245

Adverse prenatal exposure P22

Adversity P721

affect P177

Affect Regulation 13.2

affective components of pain P416

affective disorders 57.1

affective disorders risk P549

affective neuroscience P218

age P515

age of initiation P419

Ageing 5

aggression P31

Aggressive behavior P32

Aging 54, P63

aging with schizophrenia P156, P770

Aging; Cognition; Stress; Acetylcholinesterase; Splice Variants P101, P801

AI P34

Air Pollution P417

Alcohol 3, 3.2, 10.3, 35, P97, P116, P285, P288, P291, P323,

P326, P331, P333, P372, P391, P405, P729

Alcohol Abstinence P462

Alcohol addiction P357, P394

Alcohol and substance use disorders P330, P332, P336, P340,

P342, P390, P433, P460, P553, P727

Alcohol consumption 10.2, 44.4, P155, P393, P485, P716

Alcohol dependence P142, P286

alcohol drinking P285

Alcohol intake P425

Alcohol Response P300

Alcohol Subjective Response P288, P303

Alcohol Use Disorder 3.4, 35.5, P153, P311, P312, P334, P19,

P97, P294, P306, P308, P318, P337, P353, P392, P401,

P535, P537, P538, P565, P623

Alcohol Use Disorder - Treatment P117, P158, P296, P297,

P310, P315, P328, P339, P355, P456, P485, P596

Alcohol use disorder and drug addiction 3.5

alcohol withdrawal P369, P370

Alcoholic Liver Disease P99

Alcohol-seeking behavior P346

ALFF P537

allopregnanolone P310

allostatic load P332

Allosteric Ligands P359

Alpha-1A adrenoceptor P557

Alpha-Adrenergic P557

ALS P482

alternative splicing 50.3

altruism P823

Alzheimer’s Disease 13.2, P59, P609, 13, 13.3, 13.4, 13.5, 55,

55.5, P278, P486, P481, 31.2, 55.4

Alzheimer's dementia P485

Ambiguity P206

Ambulatory Assessment P278, P416

American Indian P514

AMPA receptors P189, P236, P679

Amphetamine P556

aMSM P530

Amygdala 42.4, P591, P839, P5, P175, P256, P294, P475,

P532, P590, P645, P704, P710

amygdala-based networks P586

analgesia P621, P628

Anandamide P425

anhedonia 12, 12.1, 12.2, 12.4, 51, 51.2, P573, P172, P188,

P210, P220, P223, P258, P583, P616, P673, P719

Animal Models 30, P629

Animal models of addiction P357, P363, P399, P730, P732

anorexia nervosa P409, P411, P413, P524, P412

Anosmia 49.1

Antagonist Ligands P610

Anterior cingulate cortex P423, P863, 40.4, 43.3, P81, P241,

P454, P588, P621, P740

Anterior Hypothalamic Nucleus P79

anti-brain antibodies 29.2

Anticholinergic medication burden P643

Anticipatory reward activation P229, P554

Antidepressant P204, P239, P267, P271, P659, P669, P675

Antidepressants P82, P196, P208, P268

Antifatigue P80

Antigliadin antibodies (AGA IgG) P804

Anti-inflammaory drugs P783

Anti-inflammatory drugs P225

antipsychotic P245, P249

antipsychotic drug P607

Antipsychotic drugs P812

Antipsychotic induced weight gain P444

Antipsychotic monotherapy P597

Antipsychotic Polypharmacy P30

Antipsychotic response P797

Antipsychotic Treatment P603, P643

antipsychotic-induced metabolic dysfunction P768

Antipsychotic-naïve first-episode psychosis P597, P794

Antipsychotic-naïve first-episode schizophrenia P751

Antipsychotics P598, P617

Anxeity P521

Anxiety 13.5, 56, 56.5, P5, P55, P59, P60, P140, P222, P246,

P426, P427, P459, P555, P570, P586, P634, P772, P51

Anxiety & PTSD P424, P440, P709

Anxiety and Depression P58, P61, P207, P237, P532, 4.1

Anxiety and stress P72, P200, P827

Anxiety development P54

anxiety model 41

anxiety state P62

Anxiety-related behaviors P668

Anxiety-related circuitry P53

Anxiety-related circuits 38.2

anxiolytics P61

APD-induced metabolic disease P812

Appetite P225

approach-avoidance conflict 38, 38.3, P172, P724

apremilast P565

APRO P423

architecture P34

Area prostriata 38.2

Arousal P127, P72

Arterial Spin Labeling P3

arterial stiffness P106

artificial intelligence 14, 44, P149, P38, P86, P312

Artificial Intelligence, Analysis, NeuroScience, Clinical NeuroScience, Pharmacology 2, P39, P47, P151, P376

ASD P174, P506

ASL P540

associative learning P366

Astrocyte P434, P435, P438, P820

astrocyte-enriched extracellular vesicles 36.3

astrocyte-neuron interaction P142, P826

astrocytes 30.1, P360

astrocytes, neuroinflammation, T cells, chemokines 17.1

ATAC-seq P131, P185

Attachment 6.5

Attention 56.3, P490, P853

attentional bias P54

Auditory hallucinations P168, P179, P791

Auditory Mismatch Negativity P777

Autism 55, P415, P496, P512, P531, P567, P606

Autism & depression P235

autism spectrum disorder 7.2, 20.3

Autism Spectrum Disorder (ASD) P491, P492, P493, P500,

P502, P516

Autism spectrum disorder, animal mnodel, cannabidivarin 29.2

autism Spectrum Disorders 6, 6.2, 34.2, 55.2, P165, P516

Autoantibody P560, P751

Autobiographical 39.5

autobiographical memory 39

Autoimmune encephalitis P560

autoimmunity 52, P564, P751

Automated Facial Affect Recognition P33

Automated natural speech analysis 14.1, P34, P45

autonomic nervous system 20.4

autophagy P192

aversion 19.3, P71

Aversive Learning 57.1, P475, P712

Aversive Motivation P451

avoidance P634

Axon collaterals P464

axons P144

Basal Ganglia 8.4, 18.5, P468

basolateral amygdala P81, P140, P580, P711, P842

Bayesian Modeling P66

BBB changes 17.1

BDNF P837, P840

bed nucleus of the stria terminalis P392

behavior 29, 29.5, P566, P68, 19.4

behavioral activation system P543

Behavioral approach P786

behavioral approach system P114

behavioral economics P377

behavioral genetics P726

Behavioral Health P84

behavioral inhibition system P114

behavioral mechanisms 14.3, P348

Behavioral Model P502

Behavioral Pharmacology P76, P625

Behavioral Phenotyping P50, P506

Belief Updating P66

benzodiazepine P677

benzodiazepines P486, P781

big data 22

Big Five Personality Factors P327

binge drinking P565

Binge Eating P414, P331

Binge Eating Disorder 30, 30.2, 30.3

Binge-eating disorder P410

Bioinformatics 36, 36.3, P199

biological rhythms P269, P819

Biology of aging 15

Biomarker 16, 48, 48.2, P778, P84, P88, P89, P96, P104, P302,

P704, P788, P792, P85, P332, P779, P856, P83, 36

Biomarker Candidates 5.3, P82

Biomarker Prediction 2, P100, P538

Biomarkers for Risk Assessment 14.4, P122

Biopsy 49.3

bipolar depression 23.3, P110

bipolar disorder 32.2, P107, P114, P106, P108, P110, P111,

P112, P116, P117, P118, P119, P120, P121, P123, P124,

P125, P126, P127, P148, P173, P215, P236, P279, P529,

P560, P744, P795, P819, P868, 25, 25.2, 25.3, 25.4, 27, 32, 32.1, 32.3, P810

Bipolar Disorder risk P122

Bipolar I Depression P126

Bipolar I disorder P115

bipolar II disorder 51, 51.2, P227, P121

Birth Outcomes P715

Blood biomarker P98

Blood Pressure P118

Blood-based biomarkers P59, P91

Blood-Brain-Barrier 10.5, 17, 17.3, 48.2, P108, P191, P394

BNST P827

body dysmorphic disorder P518

Body Mass Index P118

BOLD fMRI signal P182, P202, P293, P755

BOLD Signal Variability P521, P531

Borderline Personality P9

Borderline Personality Disorder P649, P662

Brain Anatomy 53.3

Brain and cardiovascular responses P202

Brain Based Markers for Depression P87, P218, P264

Brain Circuits 35.4, 4

brain connectome P393

Brain development 20.3, 24, P4, P8, P22, P324, P501, P534,

P539, P546, P550, P741, P809

brain glucose metabolism P318

Brain Insulin Resistance P252

brain iron P171

Brain organoids P133, P189, P264, P497

Brain plasticity 6, P665, P871

brain proteomics P406

brain response to cannabis cue P544

Brain States P304

brain stimulation 1.3

Brain Structure 28.3, P106, P597, P860

brain transcriptomics P609

brain wiring P648

Brain-aging 5.4, P178

Brain-Based Predictive Modeling 12.3, 48.5, 53.1, P12

brain-behaviour relationships P536

breast cancer P164

breast cancer chemotherapy P439

breastmilk 51.3

brexanolone P310, P696

Bulimia nervosa P410, P408

buprenorphine 26.2, 23, 23.4, 26.5, 34.4, P290, P849

Buprenorphine-Naloxone 23.2

CA1 P62

Caenorhabditis elegans P74

Calcineurin 21.4

calcium imaging P62, P665

Calcium signaling 21.4

calcium-permeable AMPA receptors 6.5

California mice P841

Callous-unemotional traits P182, P548

CaMKII 21.4

cAMP signalling P605

Cannabidiol P155, P395, P400, P411, P428

cannabidiol (CBD) P160

cannabidiol (CBD), tetrahydrocannabinol (THC) P429

cannabigerol P642

cannabinoid P109, P614, P642

cannabinoid receptor type 1 P16, P742

cannabinoids P505, P602

Cannabis ..... P447, P109, P160, P301, P326, P341, P433, P437, P739, P742, P748

cannabis abstinence P325

Cannabis edibles P301

cannabis use P11, P325, P368

cannabis use disorder P246, P302, P313, P314, P319, P327, P360

Cannabis Withdrawal P698

Cannabis-Tobacco Co-use P306

capsulotomy P630

Cardiac Autonomic Tone P866

Cardiometabolic Risk P768

Cardiovascular Disease P120

cardiovascular function P106

Cardiovascular Physiology 20.4

Cardiovascular Safety 47, 47.2

Career Development P281

Caregiver Support Chatbot P40

cariprazine P287

catalysis P429

Catecholamine regulation P76

Caudate P409

causal discovery analyses P41

Causal Modeling 22.4

Causal Pathways P49

CB1 receptor P617

CBD P411

CBT P521

CBT-I P214

Celecoxib P253

CELL TYPE SPECIFIC P441

cell types P705

Cell-type diversity P461

cell-type specific P625

Cellular metabolism P192, P384

Cellular senescence 15.2

central amygdala P440, P612

Cerebellum 54, P166, P759, P796, P464, 54.2, 54.3, 54.4, 54.5

Cerebral Blood Flow 20.4, P3, P120, P540, P781, P805, P868

Cerebral Cortex 21

cerebrospinal fluid P747

c-Fos P381

CFTR modulators P430

Channelopathy 25.2

Chemobrain P164

chemogenetics 21.2, P483, P623, P730

child and adolescent psychiatry P47, P530

Child development P424, P548

Childhood Adversity P418

childhood anxiety P57

childhood maltreatment P17

Childhood maltreatment exposure 48.4

childhood psychiatric symptoms 7.3

Childhood trauma 7.1, 36.4, 39.3, P16, P295, P537, P688, P708

Children and Adolescents 22.2, P4, P53, P280

ChIP-sequencing P24

Choline P504

cholinergic function P77

Cholinergic system P135

Chronic adolescence stress P14

chronic alcohol P370

chronic pain 5.2, 43.2, P315, P329, P428, P612, P640, P740

chronic pain treatment P426

chronic pain, inflammation, biomarker P602

Chronic social and non-social stress P101

chronic social defeat stress P845

Chronic social stress 3, 3.2, P21, P272, P277, P343, P724, P846

Chronic unpredictable mild stress P270, P725

Chronic variable stress P847

chrono-pharmacology 25.4

cigarette smoking P293, P581

circadian P379, P734

circadian rhythm 25.4, 27.4

Circadian rhythms P817, P282, P390

Circuit Development 29.4

Circuit dissection 54.4

circuit optogenetics P737

Circuit-function P457

circular RNA P82

Circulating cell-free mitochondrial DNA P205

claustrum 43, 43.1, 43.2, 43.3, 43.4

click-chemistry P429

clinical course 32, 32.1

clinical efficacy 51.1, P780, P802

Clinical heterogeneity P789

Clinical high risk state for psychosis P749

clinical high-risk for psychosis P805, P42, P96, P761, P777, P781

Clinical interventions P58

Clinical Neurobiology P631

Clinical NeuroScience P200

clinical outcome assessments P790

clinical outcome prediction P760

Clinical practice P698

Clinical psychiatry P631

clinical psychopharmacology 25

Clinical Subtypes P704

Clinical trial 16, 30, 42, P159, P194, P584, P660, P780

clinical trials P706

clinical trials methodology P790

clozapine P600, P800, P746

clozapine response P758

CNS Clinical Trials P162, P230, P601, P657

CNS drugs P482, P595

CNS Radiotracer P557

cocaine P335, P341, P358, P361, P365, P366, P387, P403,

P414, P723

cocaine addiction P406

cocaine reinstatement and taking P399

cocaine self-administration 50.2, P359, P384, P396, P728

cocaine self-administration and reinstatement P381

Cocaine sensitivity P728

cocaine use disorder 1.4, P186, P295

cocaine, nicotine, sex differences P399

Cognition 5, 22.1, 27.4, 54, 54.4, P2, P88, P100, P166, P173,

P175, P380, P428, P493, P622, P647, P648, P792, P869, P114,

P325, P614, P779

cognitive P58

Cognitive / behavioral flexibility 54.4, P235, P386, P678, P737

cognitive aging P507

cognitive assessment P45

Cognitive biomarkers P102

cognitive control P682

cognitive control network P168, P183

Cognitive deficits P504

Cognitive effort P167, P408

cognitive flexibility 11.2, 54.5, P396

cognitive function 54.2

Cognitive Functioning P207, P632, P646, P801

Cognitive impairment associated with schizophrenia 45.5, 55.3,

P45, P742, P770, P776, P780, P788, P806, P811, P813

Cognitive impairments 40.3, 42.2, P604

Cognitive Neuroscience P295

cognitive reappraisal P570

cognitive remediation P164

Cognitive Resilience 15.3

Cogstate Battery P242

colony stimulating factor 1 receptor 15.1

Combat PTSD P456, P695

Community Engaged Research 9

Community health center P204

Comorbidity P401

Comparative effectiveness P862

Complement 4 P808

Complement C4 28, 28.2, 28.5

Complement component 4 28.3, 28.4

complement pathway P85

Compulsive behavior P380, P668

compulsive drug intake 3

Compulsive eating 30.4

Compulsivity P489, P744

Computational Cognitive Neuroscience 57.2, P181, P184, P408

Computational Methods P182

computational modeling 57.1, 57.3, P75, P187, P756, P822, 36.5

Computational Modelling of Neuroimaging P181

computational models of decision-making P221, P322

Computational Neuroscience 39.4, P179

computational psychiatry 14, 14.1, 57, 57.4, P177, P180, P232,

P775, P822

Computational Reinforcement Learning Model P184, P729

concussion P51

conditioned place preference P352, P354, P365, P414

Conditioning Place Preference P363, P383

connectivity P765

connectome 35.5

connectomics 26.4, P183

Context P451, P621

contextual fear P25

coordinated specialty care P750

coping P480, P870

Coproduction 9

copy number variation 46.3

Correlation 25.3

Cortical Development 7.4

cortical dynamics 45.2

Cortical excitability P852

cortical GABA and glutamate P863

Cortical GABA neurons 21.1

Cortical Hierarchy P552

Cortical networks maturation P554

cortical plasticity 45.2

Cortical pruning 28

cortical thickness 17.2, 22.1, P22

Corticosterone response to stress P838

Corticostriatal circuit 30.4, P179, P480

Cortico-striatal-thalamo-cortical Circuits 38, P519

Corticotropin-releasing factor (CRF) P339, P465

Corticotropin-Releasing Hormone 29.3, P838

Cortisol P650

Cortisol response to stress P54, P785

COVID-19 P161, P243

craving 26.4, P150, P544, P640

C-reactive protein P633, P103

CRF1 Receptor Antagonist P707

CRISPR/Cas9 P503

CROSS DISORDERS P136

Cross-cultural P632

cross-species 48

cross-species research 45

CRP P173, P787

CSF P551

CSF Biomarkers 55.4, P102

cTBS P188

Cue Reactivity 11.5, P293, P297, P640, P647

cue-induced craving P647

cue-induced-reinstatement P387, P450

cue-reactivity 1.4, P176

Culture, P644

cyclic AMP P402

CYP2D6 P766

cytokine P142

cytokines P565, P690, P747

D1 dopamine receptors 18.2, 26.3, P556, P637

D1-D2 dopamine receptor heteromer P270

D2 dopamine receptor P812

daily stressors P850

Data Quality Monitoring P149

DBS P755

Decision Making 11.2, P81, P511, P618, P829, P81, P511, P618, P829

Decision tree P239

decision-making P167, P177

decison-making P718

Dectin-1 P143

Deep Brain Stimulation 27.1, P579

Deep learning P50, P491, P526, 14.2

default mode network P592

Default mode network (DMN) P713

delta9-tetrahydrocannabinol P428

delta-9-tetrahydrocannabinol P368

delta9-tetrahydrocannabinol (THC) P160

delta9-tetrahydrocannabinol, cannabidiol P426

Dementia P484, P643

Dementia Caregiving P40

Dementia-related psychosis P39

Dendritic fields P464

Dendritic Spine P840

dense sampling fMRI 11.4

dentate gyrus P178, P466

Depression 12.1, 12.2, 12.4, 23.3, 27.1, 27.3, 47.3, 48.5, 56, 56.2,

P55, P89, P91, P95, P101, P147, P150, P173, P189, P192,

P196, P197, P198, P203, P204, P205, P210, P214, P215,

P221, P222, P234, P238, P243, P251, P253, P257, P258,

P259, P261, P266, P270, P272, P275, P276, P277, P334,

P439, P469, P508, P540, P555, P580, P594, P718,

P720, P761, P817, P846, P862, P865, P11, P188, 31.3

Depression and Anxiety 13, P591

Depression Inflammation Cytokine P240, P620

Depression model 41

Depression risk P122

depression schema P211

Depression subtypes P180, P229

Depressive Mood P113

depressive symptoms 51.1, P206, P419, P639, P854

desvenlafaxine P213

deutetrabenazine P523

Developmental Programming P84

Developmental Psychopathology 44, 44.2, 48, P84, P520

Developmental trajectory 7

Dexmedetomidine P148

Diagnostic Categories P525

Diagnostic specificity P761

diffusion MRI P6

Diffusion Tensor Imaging (DTI) P368, P524, P581, P674

diffusion tractography P630, P648

Diffusion Weighted Imaging P758

diffusion-weighted magnetic resonance imaging P633

digital assessment P166

Digital Biomarkers 14.2, P203, 14.4

Digital Medicine P164

Digital phenotyping 44, 44.4, 44.5

digital psychiatry 14, P823

digital sensing 32

digital therapeutics P782

dimensional P206

Dimensional outcomes P197

dimensions of psychosis 41

Direct pathway P468

discontinuation P615

Discrimination 38.4

Disease risk prediction P42

disinhibition P848

Disrupted-in-Schizophrenia 1 P92

disruptive behavior disorders P31, P183

Dissociation P684

Distress intolerance 40.2

dmPFC P188

DNA damage response P305

DNA double strand breaks P305

DNA Methylation P20

DNA:RNA hybrid R-loop structure P145

dopamine 12, 19, P719, P65, P127, P144, P179, P243, P347,

P349, P358, P366, P389, P457, P463, P470, P480, P509,

P513, P522, P535, P556, P617, P625, P637, P678, P731,

P737, P836, 8, 8.3, 11, 11.3, 12.2, 19.2, 19.4, 26, 26.3, 38.1, 54

Dopamine (D2, D3) receptors P138, P309

Dopamine and Serotonine 8.4

Dopamine circuits 19.3

Dopamine D4 receptor P76, P610

Dopamine receptors 8, 8.2, 18, 38.3, 8.4

Dopamine, Acetylcholine P451

Dorsal Attention Network P776

dorsal raphe 13.2, P562

Dorsal raphe nucleus P27, P71

Dorsal striatum P305, P353, P396

dorsolateral prefrontal cortex P271

dorsolateral prefrontal cortex (DLPFC) 40.3, P496

dorsolateral striatum P479

Dorsomedial striatum P474, P738

drift diffusion model P186, P221

Drift-Diffusion Modelling P169

drug addiction 40.3, 43.3

drug cue reactivity P287

Drug Discovery - new approaches P50, P105, P482, P500, P595, P599

drug discovery/development P339, P617

Drug metabolism P141

drug Relapse P361, P382

Drug repurposing 10, 10.3, P382

drug seeking P293, P347, P361, P395

drug self-administration P513

drug side effects P803

drug target P357, P605

Dual Diagnosis P117

Dual Orexin Receptor Antagonists 30.2

durability of benefit P260

Duration of Untreated Psychosis P794

dynamic causal modeling P861

dynamic modeling 14.3

Dynamical Systems P857

Dynamicl system model P75

Dynamics 20.2, 56.3

Dynorphin 18.4, P460, P612

Dysfunctional beliefs P762

Dysphoria 30.3

E/I blanace P814

E/I imbalance 46.2

Early auditory information processing 46.2

early brain development 7.3

Early identification of risk 27.2, P529

Early life adversity, 7.3, P26

Early life stress 48.3, P18, P19, P20, 29.4, 48.2, P27, P29, P137, P825

early life unpredictability P172

Early Phase Drug Development P616

early psychosis P492, P542, P639, P648, P748, P750, P765

Early Trauma 48

early-life adversity 29.3, P24, P352, P435

Early-life stress/adversity P15, P17, P28, P831, P832

Eating behavior P517, P863

Eating disorders 30, P409, P411, P413, P511, P678

E-Cigarette P344

EcoHIV P143

ecological momentary assessment 11.4, P9, P41, P697, P851, P857, P858

Education and Training P37, P593

EEG 1.3, 21, 57.2, P164, P174, P477, P482, P487, P491,

P663, P746, P778, P779

EEG biomarkers 1, 45.2, 45.5, P35, P86, P92, P157, P582, P641, P815

EEG biomarkers and target engagement 45, 55.3, P235, P495, P582

EEG connectivity P87, P572

EEG synchronization 21.3

EEG/ERP electrophysiology 1.4, 45.5, P56, P211, P490

EEG-fMRI P317, P449

effectiveness P854

efficacy P757

effort sensitivity 57.4

e-field modeling P571

egocentic representation P454

electroconvulsive therapy P261, P268, P575, P755, P862

Electroencephalography (EEG) 46, 46.2, P44, P194, P254, P262, P573

Electronic cigarette (e-cigarette) P70

electronic health record (EHR) P126, P341, P643

electrophysiology 13.5, P622, P736

ELISA P560

EMA P415

emergence P734

Emerging Therapies P661

emotion P234, P821

Emotion Conflict Task P410

emotion processing 56.4

emotion regulation 11.5, P246, P415, P419, P410

Emotional dysregulation P21, P418, P870

emotional memory P663

Emotional Pain P703

emotional processing P5, P420

Emotional regulation P56, P175

Empathy P548

emulated target trial P484

endocannabinoid system 34, 34.2, P52, P16, P358, P400, P405, P596

Endocannabinoids 19.2, P123, P424, P425, P427, P455, P463, P617, P645, P830

endogenous opioids P421, P455

endophenotypes P726

endothelial cell pathology 17.1

endotoxin P147, P311

Endpoint Reliability P38

Endurance P80

Energy P225

energy metabolism P119, P754

Energy metabolism. P412

Engineered EVs 36.2

engram P78

enkephalin P71, P421

enriched environment P349

Entorhinal-hippocampal circuitry P453

Environmental exposures P278, P490

Epigenetic P98

Epigenetic Aging 48.4, P17

Epigenetic Modification P24

Epigenetic regulation 4

Epigenetics 48.3, P20, P137, P141, P190, P277, P284, P450, P715, P871

epilepsy P427, P624

episodic memory P663, P799

Epistemic Justice 9

Epitranscriptomics P277

ERP 40, P779

ERPs 40.5

Error-monitoring P632

Escape behavior 38.2

Esketamine 33, P407, P559, P604

Esketamine nasal spray P223, P263

Essential Tremor P578

estradiol 4.4, 4.2, P365, P439

Estrogen 4

estrogen receptor P73

estrogen receptor beta 4.2, P513

estrogen receptors 4.3

estrous cycle P365

ethinyl estradiol P419

event-related oscillations P777

everyday functioning P771

excitation-inhibition balance 6.2, 46.3

excitatory / inhibitory balance P688, P813

Excitatory Synapses 29.4, P809

executive function 20.2, 20.3, P19, P530, P535

executive network P682

exercise P24, P837

Exosomes P190

Expectancy P298

experience sampling methodology 44.3

explore-exploit dilemma 11.2, P180

Exposure therapy P543, P693

extended amygdala 3

Extended-release naltrexone 23.2

Externalizing behavior P283, P49

Extinction P452, P693

Extinction learning P625

extracellular matrix P360

Extracellular vesicles 36, 36.2, 36.4, 36.5, P563

eye-tracking P174

F-18 PET Imaging P39, P559

FAAH P455

face expression synchrony P821

face perception P586

Facial emotion processing P5, P336

family history 32.1

Fast-acting Antidepressant P619

fatigue P207, P225

Fatty Acid Amide Hydrolase P52

Fear P703

Fear conditioning 36.4, 39.2, P78, P681, P691, P712, P711

Fear conditioning and extinction 39, 39.3, 42.4, P417, P625, P634, P680, P710, P699

Fear extinction P424

fear generalization P63, P465

Fear learning P449, P842

fear memory P449

Fear renewal P681

female-specific vulnerability P364

Fentanyl 19.3, P351, P383, P402, P608, P667, P367

Fentanyl self-administration P404, P376, P398, P436

Fentanyl withdrawal P373, P374

FGF-21 P509

Fgf-R1 3.5

fiber photometry P347

fine mapping P337

firing rate P615

first episode psychosis P771

first-episode psychosis P154, P747, P776, P805

FKBP5 P140

Flanker Task P157

fluoxetine P271

fMRI 12.1, 37.4, 39.2, 40.5, P171, P224, P302, P531, P534,

P536, P538, P544, P551, P634, P640, P685, P748, P823

fMRI biomarkers P855

fMRI Connectivity 40.2

fMRI Effective Connectivity P336

fMRI Functional Connectivity 54.5, P784

fMRI Replication P122, P313

fMRI, anxiety, threat P57

fMRI-guided targeting P584, P233

focused ultrasound P329, P532, P580, P591

foetus brain P835

Food Addiction 30.4

food effect P767

Food Insecurity P21

food intake P472

food reward P229, P734

Forensic psychiatry P30

formal thought disorder P36

fractional anisotropy P542

fragile X syndrome P495

Free water imaging P492, P524

free-water P542

Frontal Connectivity P32

frontocingulate circuit P93

Frontoparietal Network P289

frontostriatal circuitry P583

Fronto-striatal circuits P648

frustration P589

Frustrative nonreward P423

Functional anisotropy 27.1

functional brain connectivity 54.3, P232

functional brain networks P528

functional genomics P807

functional magnetic resonance imaging P833

functional magnetic resonance spectroscopy P688

functional MRI 27.1

Functional MRI (fMRI) 31.4, 40, 54.5, P53, P168, P176, P184,

P214, P218, P295, P304, P403, P425, P496, P517, P518,

P519, P532, P549, P588, P651, P683, P764

functional neuroimaging 12.3, P319, P580, P584, P687

functional outcomes P762

G protein coupled receptors P138

GABA 19, 19.2, 37.4, 42.2, P356, P505, P713, P847

GABA and Glutamate P629

GABA MRS P300

GABA receptors P805

GABA transmission 19.5

GABAA receptor positive allosteric modulator P50, P262

GABA-A receptors P267

GABAergic interneurons P458, P623, P671, P709

GAD P61

galanin P354

gambling disorder P330

gamified cognitive tasks 57.3

gamma oscillations P187

gamma power P93

gene expression P141, P224

Gene regulation 4.1

gene transcription P265, P362

General Linear Modeling P680

Generalized Anxiety Disorder P149, P61, P151, P543, P657

Generative Artificial Intelligence P37, P46, P281

Genetic biomarker P208

Genetic High Risk Psychosis 46.2

genetic mouse model 19.4, P487, P815

Genetic Risk P49

Genetic Testing P247

Genetic variability P385

genetics P694, P728

Genetics of depression P265

genome wide association study P413

Genomic P185

Genomics P132, P413, P705

geriatric depression P199, P213

Gestational stress P717

ghrelin receptor P297

GHSR P297

Globus Pallidus P405

GLP1 P285

GLP-1 10, 10.3

GLP-1 receptor agonist 10.2, 10.4, 10.5, P95, P237, P318, P323, P340, P618

glucocorticoid receptor 29.3

Glucocorticoids P672

Glucose Metabolism P598

GluN2D P619

Glutamate 19, P356, P794, P797

Glutamate and GABA P547

Glutamate homeostasis 30.4

glutamate transporter (EAAT2) P826

Glutamatergic neurons P79

glutamatergic transmission 19.5, 46.5

Glutamine P547

Gluten-Free Diet P804

Glycolysis P846

glymphatic system P438

Glyph Allopregnanolone P242

GlyphAllo P242

goal-directed behaviors 30.1, P474

goal-directed control P176

Gonadal Hormones P393, P440, P499

GPCR 35.3, P605, P664

G-proteins 19.5

GPS P299

GReX P355

GrimAge acceleration P701

GRIN2D P619

Gut Microbiome 42.3, P856

Gut-Brain Axis P845

GWAS P283, P355, P367, P441, P442, P444, P498, P728

habenula 35, 35.2, 35.3, 35.4

habit P448

Habitual decision-making P176

hallucinations P775

HAM-A P151

harm reduction P160

Health Equity P706, P715

Health services P204

Healthcare System Change P125

health-related quality of life P55

Healthy controls P519

healthy volunteers P92

Heart rate variability P90, P415, P700

Heartbeat Evoked Potential P866

Hegemonies P644

Heroin P730

heroin choice P345

heroin seeking P722

heterogeneity P303, P531

Hi-C chromatin conformation P807

High Density Sleep EEG 55.4, P815

high fat diet P67, P467

High fat diet induced obesity 30.1

high-risk P549

Hipocampus 39.5

hippocampal connectivity P23

Hippocampal Function P24

Hippocampal neurogenesis P131, P268

Hippocampal-prefrontal P458

Hippocampus 4.1, 4.4, 37.2, P261, P268, P271, P394, P454,

P459, P466, P506, P609, P708, P814, P840, P841

hippocampus subfields P497

Histone acetylation 4.2, P717

Histone methylation P277

HiTOP 57.3

HIV 50, 50.1, P18, P690

HIV and Inflammation P400

HIV associated neurocognitive disorder 50.3

HIV-Associated Neurocognitive Disorder 50.4

Homeostasis P192

homeostatic plasticity 46.5

hormonal contraceptive use P419, P736, P870

hormone manipulation P224

Hormones P699

hospitalization risk 10.4

hostility P872

HPA axis P510

human and non-human primates P129

Human Clinical trial P231, P317

Human Genetics P285, P445, P500

Human hippocampus P867

Human Neuroimaging 5.3, 7, 20, 20.2, 20.5, 39, 39.3, 56,

56.4,56.5, P2, P35, P240, P299, P420, P424,

P493, P546, P553, P804, P867

Hymenaea courbaril P80

Hyperactivity P744

hyperalgesia P374

hyperscanning P864

Hypofrontality P146

hypothalamic-pituitary-adrenal axis P832

hypothalamus P510, P839

IAPS P764

ibogaine 45.4

IGF-1 P503

IL-1b P562

IL-1R1 P562

Imaging genomics P442

Imaging-genetics P170

Immediate early genes 3.3

Immune Biomarkers 5, 5.3, 17, P832, P859

immune cells 17.1

immune function P690

immune mechanisms P195

immune phenotype P28

Immunity, neurodevelopment & aging 15.3

Immunometabolism P225, P787

immunopsychiatry P91, P103, P783

immunotherapy 52

Implicit association test P221

Impulsive behavior P649

impulsivity 53.1, P13, P69, P241, P150, P180, P186, P474

in utero SSRI exposure P216

In vitro P608

in vivo calcium imaging P25, P366, P725

in vivo electrophysiology P843, P476

In vivo fiber photometry P77, P735

In vivo Imaging P178

incentive motivation P451

Incubation of craving P404

Incubation of drug craving 1, 1.1, 1.2, 1.3, 1.4, 43.4, P403

incubation of oxycodone craving P388

Independent Component Analysis P759

individual differences P392, P398, P506

individual variability P760

Induced neurons P808

induced pluripotent stem cells 46

Induced pluripotent stem cells (iPSCs) 32, 46.5, P133, P134, P189, P497

Infant fMRI P498, P548

infant neuroimaging 7.2

infection P566

Inflamation 48.4, P804, 17, 17.2, 49.3, P108, P334, P29, P88,

P103, P158, P210, P254, P258, P307, P633, P719

Inflammation and cytokines P85, P97, P286, P311

infralimbic cortex P452

Inhibitory control P186, P408, P688

Inhibitory interneuron signaling P466

Inhibitory interneurons P421

inhibitory neurons 21.3

Innate defensive behavior P79

insomnia P214, P248, P290, P818

insomnia disorder P818

Insula Connectivity P550

insula cortex P550, P825

Insula, P90

insular cortex P294, P472

insulin P812

insulin resistance P258, P507

integration of GWAS with brain omics P185

integrative neuroscience P199

Intellectual disability P491

Interactomes P136

interbrain synchrony P864

Interdisciplinary P420

Interferon Response Factors P103

intergenerational neuroimaging P520

Intergenerational Transmission 7.1, P17, P831

Intergenerational transmission of trauma 39.3

internal capsule P630

Internal state modulation 38.2, P74, P668

internalizing disorders P56

interneurons P422

interoception P147

Interpeduncular nucleus 35.5

interpersonal violence P697

interval timing P166

interventions P427

Intracellular Signaling P664

intralaminar thalamus P396

Intravenous self-administration P407

intrinsic connectivity (fMRI) P550

ion channel P616

Ion channels 25.3

iPSC 46.4

iPSC-derived neurons 32.3, P123, P338

irritability 44.2, P423, P589

Irritability/Aggression P855

isolation P841

iTBS P576

IV ketamine P89, P93, P561, P684, P720, P854, P862

IV- Ketamine P173, P215

kappa opioid receptor 18.4, 26.5, 45.4, P612, P649

Kappa Opioid Receptor Antagonist 34.4

KCC2 P813

Ketamine 23.3, 31, P222, P83, P194, P197, P540, P558,

P604, P849, 31.3, 33

Ketogenic diet 25.2, P67, P300, P328, P412, P484

ketone monoester P328

kratom P321

Kynurenic acid P504, P561

Kynurenine P504

kynurenine pathway P505, P561

L1 retrotransposons P721

Lactate P83

lactate shuttle P645

Lamotrigine 25.2

Language 56.3, 56.5, P652, P752

Large Language Models 14.2, 44.2, P36, P40, P42, P46, P638

Large Scale Networks 20.2

Late Life Depression P202

Late-life Depression P262

latent profile analysis P31, P114, P848

latent states P838

Lateral Habenula P369, P370, P469

Lateral hypothalamus P27, P820

Lateral Septum P129

Lay Community Health Workers P644

LC P551

learning and memory 45.3, P325

learning generalization P184

Learning Health Network P125

lemborexant P818

Leptin P472

life stress P851

Lifespan 20.3, 54.3

limbic system P843

Lipid metabolism P258, P273

Lipidomics P59

lipocalin-2 P566

Lipopolysaccharide 36.3

Lithium P624

Lived Experience 9

local field potentials 27.1, P487

local gyrification index P542

locomotor activity P282, P283

Locus coeruelus 13.4

Locus coeruleus 13.5, P72, P464, P774, P615

Locus coeruleus (LC) 13.3

loneliness P280, P798, P822

long noncoding RNA P145, P294

Long-acting antipsychotics P636

long-acting injectable P636

Long-acting injectable antipsychotics P789, P803

long-COVID P161

longitudinal analysis 44.3, 57, P43

longitudinal change P544

longitudinal imaging P536

longitudinal multimodal imaging P309

longitudinal studies P215

longitudinal study P102

Long-non-coding RNA P276

long-range chromatin interaction P145

long-term P244

long-term results P660

Low Intensity Focused Ultrasound P578

Low-dose methotrexate P783

LSD P657

LSD microdosing 47.2, 47.3

lumateperone P219, P244, P245, P249

M1 and M4 Muscarinic Receptors P637

M1 Muscarinic Receptors P763

M4 muscarinic acetylcholine receptor (mAChR) P159

machine learning 5.2, 14.4, 44, 44.2, 53.1, P98, P477, P7, P12, P44, P45, P47, P170, P230, P398, P793

Machine Learning Classification P68, P33, P39, P48

Machine learning clustering P35, P788

Macrophage 17.2

macrophages 17.1

MADRS P37, P151, P263

Magnetic Resonance Imaging 27.4

magnetic resonance spectroscopy P107

magnetic resonance spectroscopy (MRS) P797, P547

magnetoencephalography P93, P195, P212, P232, P776, P861

maintenance treatment 26.4

Major depression 12, 36.2, P246, P585, P849, P859, P230

Major Depression Disorder P20, P33, P226, P263, P533, P543

Major Depressive Disorder P191, P236, P239, P292, P587, P244, P245, P249, P260, P601, 27, 36.3, 47, 47.2, P208, P274, P575,

P35, P86, P131, P163, P201, P219, P231, P233, P247,

P248, P250, P256, P529, P547, P588, P662, P850

major psychiatric disorders P646

maladaptive avoidance 57.1, 57.4

mania P107

mania biomarker 27.2, P122

manic symptoms P112

marmoset P274

massage P90

maternal behavior P73, P717

maternal brain P317, P864

maternal care 6.4

Maternal Depression P224

maternal functioning 51.3

maternal sensitivity P700

maternal stress 6.4

Matrix Metalloproteinase-9 (MMP-9) P844

Matrix Metalloproteinases P360

MDD P44

MDD, PTSD P708

MDMA 6.2, 34.3, P456, P651, P666, P693, P828

measurement-based care P112

mebufotenin P227, P228

mechanism-based biomarkers 2

mechanism-based phenotyping 57.4

mechanisms 41

MeCP2 P487

medial habenula 35.5

Medial Prefrontal Cortex 38.3, 38.4, P165, P358, P391, P421, P465

Medial Prefrontal Cortex (mPFC) 6.3, 49.2, P14, P78, P146, P362, P381, P460, P470, P480, P568, P709, P811, P834

Medication adherence P780, P786

medications P290

mediodorsal nucleus of the thalamus P681

Medium Spiny Neuron P139

Medium spiny neurons 8, 18.3

MEG 56.2

Memory 4.3, 31.2, 39.5, P447

Memory and Learning P68, P74, P453, P506

memory engram cell P361

Mendelian Randomization P124, P285, P442

menopause 37.4, 37.5

Menopause, Mood, Childhood Stress, Neuroendocrinology, Women's Health, Sex Differences 37.2

Menstrual Cycle P865, P866, P867

Mental Disorders P104

Mental Health P432, P824

Mental health outcomes 22, 22.4, P204, P553

mental illness P595

Mentalizing 56.3, P567

meta-analysis P111, P130, P198, P251, P549, P596

metabolic P222

metabolic function P88

Metabolic Psychiatry 25.2, P408, P413, P768, P812

Metabolic side effects P248, P598

metabolism P484, P485, P748

metabolomics 42.3

Metabolomics signature P89

metabotropic glutamate receptor P709

metabotropic glutamate receptor 5 (mGluR5) P606, P825

Metaplasticity P655

metformin P341

Methadone 26.5, P602, 26.2

Methamphetamine 1.3, P146, P150, P351

Methamphetamine use disorder 1.4, P322, P352

methylone P162

Methylphenidate P552

mGlu5 5.5

mGluR2/3 negative allosteric modulator P194

mice P146, P80

microbiome P348, P845

microcircuit processing P461

Microdosing with psychedelics 47, 47.1, 47.4, P670

microglia 15, 15.1, 15.2, 15.3, 29.4, 29.5, P373, P435, P436,

P437, P563, P564, P747, P343

microglia and neurons 28.5

microglia-neuron interactions 29, 29.3

MicroRNA P265, P284, P342

microRNAs 46.5

microstructural imaging P758

midbrain P462, P795

Mild Traumatic Brain Injury 31

Mindfulness Meditation P573, P682

miRNAs 36, 36.3

Mitochondria 46, P18, P190, P276, P384, P841, P846

Mitochondrial DNA P119

Mitochondrial dynamics P388

mitochondrial dysfunction P205, P375, P120

mitragynine P321

mitragynine pseudoindoxyl P321

Mixture modelling P714

mobile sensing P279

Modifiable Risk Factors P278

Molecular imaging P508

molecular mechanisms 50.4, 25.3, P224, P338, P190

Molecular neuropathology P130

Molecular Pharmacology P138, P664

monetary incentive delay task P229

Monetary reward P220, P229

mood and anxiety disorders P66, P207

Mood and Cognition P108

mood disorder 27.4

mood disorders 32.2, 33, P88, P212, P332, P819

mood induction 56.2

morphine P414

Morphine sensitivity P67

mother-child dyad P520

mother-child dyads P864

mother-infant interaction 51.3

motivated behaviors 8.3, 43.1

motivation P2, P210, P364, P719, P723, P731, P734, P738

motor function P99

motor learning P656, P658

motor stereotypies P446

mouse P503

mouse brain P741

Mouse model 25.3, P814, 53, P392, P624, P847

movement disorders P523

mPFC P276

MRI 27, 53.3, P111, P236, P492

mRNA P795

mRNA translation 31.2

MR-PET P635

Mu opioid receptor 18.2, 19.5, 26, 26.3, 35.4, 26.2, P139, P284, P321, P354, 8.3, P628

mulocclusion P816

multimodal P542

multimodal biomarkers 36.5

multimodal data P1

Multimodal imaging P183

Multimodal Neuroimaging 53.2, P12, P514, P781, 37, P805

Multimodality neuroimaging 53

Multiomics 50.2, 50.4

Multi-omics P195

Multivariate analysis P599, P760

multivariate data fusion P171

multivariate pattern analysis P518, P538

mu-opioid receptor agonist 34.4

muscarinic M1 P811

MVPA 39.4

Mycobiome P143

myelin P51

Myelination P501

myo-inositol P797

N-acetylcysteine P154

NAD+ P161

naltrexone P345

Native American populations P848

natural language processing (NLP) 14.1, P43, P96, P798

Natural rewards 19.3

Naturalistic Paradigms 56, 56.2, 56.4, 56.5, P304

Negative Affect P322, P772

negative allosteric modulator P372

negative emotionality P19, P308

negative reinforcement P463, P735

Negative Symptoms 49.3, P156, P639, P762, P787, P761, P782

Negative urgency P852

Neighborhood Socioeconomic Deprivation P240

neocortex 21.3

neonates 7.4

network neuroscience P791

Network-Analysis 28.5, P302, P703

Neural activation P14

neural cicuitry P733

Neural circuit and animal behavior P393

neural circuits 6, 6.2, P511, P709

Neural decoding P62, P449, P477, P851

Neural flexibility P521

Neural mechanism P685

Neural networks 48.5

neural oscillations P577, P718

Neural Plasticity P867

neural progenitor cells P265

Neural Reward Circuitry 12.3, 40.4, P77

neuritogenesis P594

neurobiological subtypes 17.3

neurobiology, stress, depression, anxiety P273

neurocircuit mechanisms of addiction 18.5, 50.4

Neurocircuitry P651

Neurocircuits 1.2, P477

Neurocognitive assessment P15

neurocognitive function P113

neurodegeneration 15, 15.2, P85

Neurodegenerative Disease 31, P136

Neurodegenerative disorders 31.5

neurodegneration 31.3, P375

neurodevelopment 29, 53.1, 28, P563, P622

Neurodevelopmental and psychiatric disorders P490

Neurodevelopmental Disorders P488, P499, P526, 20

neurodevelopmental disorders, cannabidiol, CBDV, translational models, clinical trials P489

Neuroendocrine P736

neuroendocrinology 37.3

neuroepigenetics P674

neurofunctional domains P332

Neuroimage 11.5

neuroimaging 31.3, P96, P555, P558, P583, P741

Neuroimaging Analysis P200, 20.4

neuroimmune P565, P343

neuroimmune activation P725

Neuroimmune communication 49, 49.1

neuroimmune mechanisms P142, P147, P368

Neuro-immune regulatory System (NIREGS) 28, 28.5

neuroinflamation 17.3, P456, 15.2, 30.1, P128, P253, P269,

P401, P566, P765

neuroinformatics P34, P181

Neurokinin 3.2

Neurological and Psychiatric Disorders P595, P656

neuromelanin P541

Neuromelanin-sensitive MRI P492, P522, P541, P774, P784

Neurometabolism 55.5

Neuromodulation 6, 6.3, 38, 55, 21.2, P329, P568, P578, P586, P593

neuromodulators P473

Neuronal ensembles P387, P475, P621, P667, P830, 6.5

Neuronal excitability 32.3

Neuronal Oscillations P254, P573

neuron-derived extracellular vesicles P95, P507

neuropathic pain P41, P611, P612

neuropeptides P74, P391, P510, P712, P827

neuropharmacology P626, P677

Neuropharmocology P606, P611

Neuroplasticity 37.3, P626, P238, P594, P658, P675

neuroplastogen P231, P627, P692, 31.2

Neuropsychiatric Disorders P136, P726, 18.2

Neuropsychiatric Disorders [Schizophrenia, Parkinson's Disease, Major Depressive Disorder] 31.5

neuropsychiatric indications P429

neuropsychiatric symptoms 37

Neuropsychiatric symptoms (NPS) P486

neuroscience 16

Neurosteroid P242, P257, P696

Neurostimulation P573, P587

neurosurgery 5.2

neuroticism P234, P555

Neurotoxicants P604

neurotranscriptomics P346, P614

Neurotransmitter release P144, P737

Neurotrophins P829

Neurovascular P191

Neurovasculature P26

new intervention targets P529

NF-kappaB P103

nicotinamide riboside P161

nicotine 11.3, P344, P513

nicotine addiction P70, P306

nicotine dependence P592

Nicotine exposure P349

nicotinic acetylcholine receptor 35.5

nicotinic acetylcholine receptors P372

nightmares P689

Nitazene P628

Nitrous Oxide P157

NMDA Antagonists P201

NMDA glutamate receptors P601, P619

NMDA Receptor P560

Nociceptin/orphanin FQ P727

noncoding RNA 36.2

Non-hallucinogenic P627

Nonhuman Primate Models P399

Nonhuman Primates P140

non-human primates P377, P556, P558

Non-invasive Neuromodulation P32, P235, P316, P457, P682, 45.3

Non-opioid, Non-addictive Therapeutics P371

Non-Pharmacological Therapy P864

Non-Suicidal Self-injury (NSSI) P6, P416, P545

nonsuicidal self-injury disorder P541

norepinephrine 13, 13.5, P478, P615, P707, P464

Normative Modeling 39.2, P525, P597, P796

Nos1 21.1

novel methods P558

Novel Rapid Antidepressant P201

Novel Targets P105, P588

novel therapy 42

Novel treatment 25

Npas4 P145, P146, P387

NR2B NAM P250

NREM sleep 21, 21.3, 55.5, P262, P770

nT2* P171

Nucelus accumbens 4.4, P461, 3.2, 6.5, 18, 18.2, 18.3, 29.4,

50.1, P364, P836, P423, P138, P272, P390, P395, P406, P467,

P473, P618, P817, P830

nucleus accumbens (NAA) P350

nucleus accumbens core P366

Nucleus Accumbens Shell 8.3

nutrition P509

Obesity 22.2, P517, P600

Obesity and eating disorders 30.4

Obsessive Compulsive Disorder 44.4, P445, P519, P630, P632

obsessive-compulsive disorder P633

Obsessive-Compulsive Disorder (OCD) P157, P579, P631, P634

Obsessive-Compulsive Eisorder (OCD) P635

Obsessive-compulsive personality traits P55

obstructive sleep apnea P770

Olfaction 49.1, 49.3

olfactory 49, 49.2

Olfactory epithelium 49.3

oligodendrocytes P51, P134, P137, P437

Open Chromatin Regions 53.4

Open Label Trials P314

open science P546

Operant behavior P468

opiate P367

Opioid 10.3, P28, P291, P373

Opioid abuse P317, P371, P385

opioid addiction 11.4, 18, 26, 26.3, 35, 50.1, P98, P292, P338, P350, P356, P362, P602, P647, P732

Opioid agonist treatment 26

Opioid craving P307, 43.4

opioid dependence P177, P375, P397

opioid dependence, pharmacotherapy, animal model, withdrawal 8.3, P139, P371

Opioid Mortality 44.5

opioid overdose 23.4

Opioid peptides 35.3

opioid sparing P613

Opioid system P540, 34

opioid tolerance P67, P621

Opioid treatment P299

opioid use disorder 18.3, 23.2, 26.2, 26.4, 35.2, 26.5, P404,

P304, P312, P176, P290, P307, P316, P320, P364, P376,

P378, P407, P436, P609, P722

opioid withdrawal P67, P139, P316, P397

opioids 43.2, P343, P608, P377

Opioid-sparing effects P371

OPRM1 gene 35.2

optical biosensors P389

optogenetics 19.4, P735

orbital frontal cortex P396, P840

Orbitofrontal P829

orbitofrontal cortex 30.1, P388, P409

orexin receptor 2 agonist P274

orexin/hypocretin 30.2, 30.3, P274, P820

organic cation transporter 3 P711

Organoids 46.4

orphan receptors P605

OUD P551

Outbred mice P374

outcome controllability 57.4

ovarian hormones 11.3, 4.1, P867, P714

overeating 30.3

oxycodone 1.1, 1.2, P284, P347

oxytocin P347, P512, P823, P827

P3b P778

PACAP 42.4, P371, P704, P712

Pachyman P143

Pain 5, 5.4, 43, 5.5, P71, P288, P291, P307, P334, P369, P641, P645, P697

pain analgesia P416, P455

Pain sensitivity P462

Pancreatic Euglycemic Clamp P598

panic disorder P401

panss P767, P872

parabrachial nucleus P397, P712

parahippocampal gyrus 17.2

paraventricular nucleus of the hypothalamus 29.3, P837, P838

paraventricular nucleus of the thalamus 3, P459

Parent - child dyads P317, P685

Parental Factors P49, P57

parenting distress P21

Parkinson's disease P652

Partial agonist Ligands P610

parvalbumin P844

Parvalbumin fast-spiking GABAergic interneurons P466

parvalbumin interneurons P452

parvalbumin interneurons/perineuronal nets P386

Parvalbumin neurons P130

passive sensing 14, 14.3, 44, 44.2

pathophysiology 25

Patient outcomes 16

Patient Reported Outcomes P162, P750

Patient Selection P247, P230

patient-centricity P782

pattern separation P25, P178

Pavlovian conditioning P467

PBMC P98

pediatric P427

Pediatric anxiety disorders P53

Peer Stress P218

Perceived stress 36.5, P656, P833

periaqueductal grey (PAG) P381, P460

Perimenopausal Depression P193

Perinatal development P821

Peripheral-Central Nervous System Interface 49

persistent avoidance P206, P363

personalized medicine 25.4, P56, P590

PET P10, P637

PET imaging 5.5, 26.5, 5, 15, 15.1, 27.4, P747, P16, P236, P243, P631, P649, P784, P850

PET Imaging Study P52, P509, P679

phantom pain P653

Pharmacodynamics 45.5, P654

Pharmacoepidemiology P430

pharmacogenomics P213, P444

pharmacokinetic P367

Pharmacokinetics 10.5, P208, P213, P654, P767

Pharmacologic augmentation P800

Pharmacology 20.5, P500, P813

pharmacotherapy P158, P818

Pharmacovigilance P430

Phase 1 P155

phase 1 study P159

Phase 2 P692

Phase II clinical trial P601, P802

Phosphodiesterase-4 (PDE4) 45.5

Phosphodiesterase-4B (PDE4B) P402, P620

phosphorylated IRS1 P507

phosphorylation 21.4

Photometry P468

physical activity P203

Physical exercise P496

Pilot Study P598

PKA 21.4

Placebo Effect P455

Placebo effects 5.4

Placebo Response P44

placebo-controlled trial P802

placenta P503, P564, P835

placenta stem cell models P132

Placental Inflammation P84

plasticity 31.3, P272

Platelet derived growth factor P383

pleiotropy analysis P442

Polydrug Use P326

Polygenetic Risk Score P115, P120, P860

polygenic risk scores P646

Polygenic scores P745

polysomnograph P214

polysubstance use P319, P324, P351, P399

pooled P244, P245

Population Assessment P432

Population Health P553

Population neuroscience P493

Positive Affect Treatment P56

positive allosteric modulators P159

positive mood 47.3

positron emission tomography P633, P402

Positron Emission Tomography (PET) Imaging 26, 26.2, 26.3,

P523, P528, P556, P557, P763, P771

Post Traumatic Stress Disorder 39.5, P681, P689, P691

Posterior Cingulate Cortex 39.5

Postmortem P817

Postmortem Brain Tissue P135, P305

Postmortem Brain Tissue Gene Expression 13.4, P819

Postmortem human brain study P342

Postmortem Human Brain Tissue P124, P128, P292, P810

Post-operative neurocognitive disorders P438

postpartum 6.4

Postpartum caregiving P831

postpartum depression 51, 51.2, 51.3, P659, P193, P713

Postpartum mental health P685

Postpartum Period P869

post-sepsis P566

Postsynaptic transmission P14

posttraumatic stress P704

Posttraumatic stress disorder (PTSD) P360, P401, P685, P687

Post-traumatic stress symptoms P683

Potential rapid anxiolytic effects. P64

PPARγ agonist P95

Prader Willi Syndrome P489

prairie voles 6.5

pramipexole 12, 12.1, 12.2, 12.4

prazosin P557

precision functional mapping 7.4, P536, P568

precision health 16

Precision Medicine for Depression P247

Precision Medicne neuropsychiatric diseases P355

precision psychiatry 12.3, P105, P38, P45, P100, P211, P594,

P607, P630, P651

Precison mental health P105

Preclinical Alzheimer's Disease 37.5, P483

Preclinical assessments P376

Preclinical models and endpoints 42, P677, P724

Pre-clinical screening 14.1

Predictive Biomarker P44

Predictive coding P638

Preeclampsia P869

prefontal cortex P394

prefrontal cortex 21.2, 29.5, 48.3, P294, P345, P350, P417, P422, P623, P847, P76, P813, P622

pregnancy P418, P563, P715, P716, P869

pregnancy/postpartum 37.3

Pregnenolone P257

premenstrual dysphoric disorder P193

Prenatal P504

Prenatal alcohol exposure P716

prenatal depression P216

Prenatal Drug Exposure P346

Prenatal exposure 7.1

Prenatal immune exposures 15.3, 29.2

prenatal stress P835

Prenatal Stress Model 42.3, P563

Prescription Opioids 18.5, P329, P385, P641

preterm birth P530

Probabilistic learning P448

probabilistic reversal learning P75, P448, P737

Procyanidin P80

Progesterone P866

Pro-inflammatory cytokines P717

Prolonged Exposure Therapy P152, P701

Propofol P262

Prospect theory P13

protective factors P514

Proteomics 36, 36.5, 46.4, P104, P131, P144, P481, P666

proton magnetic resonance spectroscopy P713, P863, P241

Prucalopride P64

Psilocin P667

Psilocybin 31.4, P251, P338, P486, P635, P652, P655, P662, P663, P666, P671, P672, P676, P677, P678, P710, P653

Psilocybin mushrooms 47.1

Psilocybin therapy 31.5, P314, P660

Psilocybin truffles 47.1

Psychedelic P659

psychedelic drugs P163

Psychedelic effects 47.4, P656

Psychedelic medicine P673

Psychedelic therapy P653

Psychedelics 31, 45.2, 45.4, 47, P121, P195, P217, P267, P635,

P650, P654, P657, P658, P661, P663, P664, P665, P666,

P668, P669, P670, P671, P675, P676, P677, P693, P722

psychiatric and substance use disorders P636

Psychiatric Comorbidity P215

psychiatric diagnosis P46, P494

psychiatric disorders P269, P441

psychiatric genomics P443

psychiatric illness 34

Psychiatric Risk 7, 14.2, 4

psychoactive molecule 51, 51.1, 51.2, 51.3

psychoactive molecules P227, P228

psychological distress 44.5, P431

Psychological Pain P858

psychological wellbeing P113, P553

Psychometrics P259, P327

Psychoneuroimmunology P561

psychopathology P494, P22

psychophysics P602

psychophysiology P415

Psychoplastogens P231, 31

Psychopthology P600

psychosis P36, P481, P592, P638, P744, P759, P775, P793,

P796, 49, 52, P525, P772, P783

psychosis risk P549

psychosis spectrum disorders P102

Psychosis spectrum symptoms P10, P181, P536, P599, P760, P801, 46, 57.2

Psychosis-Risk P48, P793

Psychosocial behavior P143

psychosocial stress P381

psychostimulants P806, 1.1

Psychotherapy P43, P543

Psychotic Disorders P756

psychotic-like experiences P1, P7, P745, 37.2

PTSD P152, P162, P222, P310, P448, P532, P590, P627, P650,

P665, P679, P682, P684, P690, P692, P693, P694, P696, P697,

P698, P700, P701, P702, P703, P705, P706, P715, 4.3, 14,

14.1, 39, 39.4, 42.4

Puberty P4, P60, P443, 53.4

public health 22.2

pupil P551

pupillometry P72

qualitative interview P312

qualitative research 44.4

quality of life P112

Quality of LIfe (QoL) P113

Quantitative Electroencephalography (qEEG) P577

Quetiapine P248

Rabies tracing P676

Racemic Ketamine and metabolites P195

Racism and discrimination stress P687

raclopride P509

Randomized Clinical Trial P157, P158, P315, P782, P851, P447

randomized controlled trial P316

Randomized Double-Blind P201

Randomized-Controlled Trial P306, P411, P849, P854, 47.2

Raphe-Accumbens P69

Rapid-Acting Antidepressant P194

rapid-acting treatment P162

Rare genetic variants P133, P446

Rare genetic variation P445

Rats P344, P618

RCT P508, 12.1

Real World Data P61, P196

real-time fMRI neurofeedback P256, P570

real-world practice 33

Receptor maps P599

recognition memory P683

Recovery P126, P320, P412

redox dysregulation P29

regulatory compliance P34

Regulatory T cells P783

Reinforcement learning P349, P476, P678, P731, P761

Reinforcement-based decision-making 57.1

reinstatement P378

relapse P260, P312

relapse prevention P261, P266, P803

REM sleep P238, P820

remission P244, P263

Renin angiotensin system 29.2

repetitive transcranial magnetic stimulation (rTMS) P87, P403,

P577, P589, P799

Replication P53, 27.2

Representational similarity analysis P518

reproductive transitions 37

resilience P480

Resilience to childhood maltreatment and anxiety P23

Response inhibition P632

Resting and task fMRI 20, 20.4

Resting State Connectivity P257, P853

Resting State Functional Connectivity P216, P226, P252, P311,

P498, P533, P550, P558, P674, P689, P713, P781, P796, 7.4

Resting-state fMRI P515, P527, P545, 27.3

resting-state functional connectivity P592

Retinal imaging P868

retinoic acid 1.1

Rett Syndrome P487

Reward 11.3, 12.2, 18.4, P11, P719, P25, P169, P298, P474, P723, P764

reward and aversion P461

Reward Circuitry P3, 27.2

reward learning P75

reward motivation and decision-making 11

reward prediction error P731

reward processing P23, P77

reward response P718

Reward seeking P378, P434, P725

Reward self-administration P721

Reward sensitivity P13

Reward, motivation and Anhedonia P200, P219, P718, P727, P733, 4.4

Reward, motivation, and anhedonia P787, P865

Reward-based decision-making P799

rhesus macaques P400

right temporo-parietal junction P567

Risk and Resilience P303, P431, P694, 48

Risk Calculator P7

Risk factors P726

Risky decision-making P76, 11.4

R-ketamine P407, P404

RMTg P369

RNA Sequencing P15, P397

RNAscope fluorescence in situ hybridization P357, P847

RNAseq P268, P345, P373, P740

RNA-seq P131, P185

Rodent models P728

Rodents P402

rTMS 40.5

rumination P66

s100a10 P273

Safety 51.1

Safety profile P430, P657

Safety/tolerability 47.2

SAINT P233

salvinorin A P710

schizophrenia P174, P481, P778, P779, P782, 54

Schizophrenia (SCZ) 17.3, 28.2, 46.4, 55, 56, P48, P85, P133,

P148, P159, P441, P600, P743, P744, P751, P753, P755, P757,

P773, P785, P786, P787, P788, P790, P791, P794,

P800, P802, P803, P809, P810, P814, P872

Schizophrenia (SZ) 17, 17.2, 28.4, 54.3, P132, P187, P754, P763, P792, P795, P797, P798, P802, P808, P828

schizophrenia and bipolar disorders P102, P815

schizophrenia and cognition P806

Schizophrenia and related disorders (SRD) P128, P515, P575, P742, P784, P804

schizophrenia negative symptoms P811

Schizophrenia novel treatment P605

Schizophrenia- Novel Treatment P606, P763

Schizophrenia Spectrum Disorders 28.3, P752, P531, P789

Schizophrenia Spectrum Illness 17.3, P768

Schizophrenia subtypes 28

Schizophrenia, Antipsychotics P603

Schizophrenia, Dopamine, Antipsychotics P607

Schizophrenia, negative symptoms 34.4

Schizophrenia; Functional Capacity; Antipsychotic Treatment P806

Seasonality P819

second order conditiong P287

Sedentary Behavior P156

selective attention P861

Self-Administration P335, P344, P351, P387, P450

self-compassion P23

self-control P167

Self-harm P30

Self-medication with psychedelics 47.4

self-other processing P720

self-referential processing 57.2

Self-titration 47.1

Semaglutide P237, P768, 10.3

Semantic prediction error P638

sensitization P837

Sensory neurobiology P611

sensory processing 55.2

serotonergic system 34

Serotonin P27, P144, P234, P335, P453, P473, P562, 8, 13, 13.2

Serotonin 1b receptor P474

serotonin 2A receptor P626

Serotonin 4 receptor P508

Serotonin 5-HT2A Receptor P676

serotonin clearance P711

serotonin receptors P376, 8.4

serotonin transporter P711

serum levels P99

Sex Chromosomes 53.3

sex difference 4.3, 37.5, 53.2, 4.1, P28, P721, 11.2, 11.5, 53,

53.1, P183, P263, P270, P275, P336, P369, P379, P386,

P398, P486, P499, P511, P537, P726, P729, P739, P833, P699,

P853, P276, P404, P868

Sex Hormones 11, 11.5, 53.3, P871, P73, P443, P508

sex steroid hormone receptors 53.4

sex-differences P740, P741

sex-specific effects 11.4, 11, 28.2, 35, P26, P342, P349, P465

Sex-specificity 28.3

Sexual Dimorphism 53.3, P346

Shank3-deficient mice P830

SICI P792

Simulated Driving P301

simulated reasoning P46

Simulation P266

single cell omics 35, 53

Single nucleus RNA sequencing 35.2, 50, P124, P129, P135

single nucleus RNA-seq P809

single-cell P185

single-cell genomics P292, P337

Single-cell RNA sequencing P130, P378

Single-cell transcriptomics 18.5, 53.2, P382, P810

single-nucleus RNA sequencing 50.2

single-nucleus RNA-sequencing P136

Single-unit electrophysiology in vivo P579, 43.1

SLC39A8 genotype P333

sleep 4.2, 21.2, 44.4, P282, P785, P203

sleep diary P818

sleep disordered breathing P816

sleep disturbance 25.4, 55.2, P101, P117, P161, P246, P426, P714, 13, 13.2, 44.3, 55.5, P308

Sleep homeostasis 21.1, 21

Sleep oscillations 45.3, 55, 55.3, 55.5, P773

sleep physiology 55.2

sleep spindles P815, 55.2

sleep-dependent learning P770

slice electrophysiology P142

Slow wave activity 21.1, 21

slow wave sleep 13.3

smartphone 22, 22.1, 22.2, 22.3

smartphone apps P280, P299, P858, 44.3

Smoking P298

Smoking Cessation P306

SNAP25 P624

snRNASeq P140, P708, 3.3, 3.5

snRNA-seq P441

sociability P29

social anhedonia P720, 44.3

Social Anxiety Disorder P52

Social Behavior P81, P435, P470, P473, P822, P826, P829,

P830, P831, 6, 6.3, 7.2, 34.2, 34.4, 49.2

Social buffering P733, P827

social cognition P174, P295, P496, P828

Social Competence P81

Social defeat 3.3

Social defeat stress P620

Social Deficits P165, 6.2

Social epidemiology P431

Social exclusion 3.4

Social interaction P14

Social Interactions 34.3, P823, P502, P567

social isolation stress P469

social learning P825

social loss P841

social media 22.4

Social media language 44.5

Social Media Use P280, P824, 22, 22.3

social neuroscience 34

social perception 57.2

Social Processing P752, 34.3

Social reward P730

Social support 48.4

Sociocultural Factors P327

Socioeconomic Status (SES) P17

somatic mutation P305

Somatostatin P422, 38.4

Somatostatin-expressing interneurons P130, P452, P466, 38.4

Spatial Navigation P454

spatial proteomics P128

spatial transcriptomics 13.4, 15, 18.2, 18.3, 35.2, 50.1, P129, 50, P483

Spatial working memory P458

speech processing P638

speech production P658

SPT-300 P242

SSRI P271

SSRI treatment P615

Stages 24

statistical methods P585

Stigma 9

stimulant P110

stimulant use disorder P572

Stratification P651

stratified precision medicine trial 12.3

stress P839, 29

Stress and Trauma P691, P694, 48.5

Stress reactivity P647

stress resilience P275, P845

stress resilience and susceptibility P825, 4.2

Stress Response 3.4

stress responsivity 37.4

stress vulnerability P839

Striatal Dopamine signaling P270, 8.2

striatum 8, 8.2, P476, P65, P373

Stroke P658

Structural MRI P115, P261, P516, P526, P702, P745, 28.4

structural neuroimaging P488, P530, 22.1, 46.3

structural variants P807

Structure based design P613

subjective effects P684, P739

Substance abuse P220

Substance abuse disorders P348, 40, 50

Substance P 3.2

substance use P23, P379

substance use disorder P367, 40.5, 48.3

Substance use disorder treatment 10.4, 40.4

Substance Use Disorders P118, 1, P309, P329, P384

Substance Use Initiation P3, P48, P534, P539

substantia nigra P774

subthalamic nucleus P356

Subtyping P703

SUD and HIV 50.2, 50.3, 50.4

SUD risk P327

Suicidal behavior P852, 23

Suicidal ideation P587, P852, 23, 23.2, 23.3, P850, P851, P858

Suicidality P217, P854, P855, 28.2

Suicide P853, 23.4, P6, P237, P860, P865

Suicide Assessment P857, P858

Suicide attempt P649, P856, P859

Suicide ideation P848

Suicide prediction P212, P857, 57.3

suicide prevention P749, P849, P862, 57.3

Suicide risk P848

Suicide risk factors P241, P331, P749, P861

Sustained remission P202

Symptom dimensions P528

Symptom stability P769

symptom structure 32.1

Symptom Trajectories P832

symptom trajectory P639

Symptoms P259

Synapse P846, 29

synapses 29.5

synaptic connections 49.2

synaptic density P771

Synaptic Function P10, 4

synaptic physiology 18.5

Synaptic Plasticity P559, P619, P676, 1, 1.1, 4.4, 31.2

synaptic pruning 28.5

Synaptic Vesicle Glycoprotein 2A (SV2A) P528, P771

Synaptogenesis P594

Synthetic Cannabinoids P346

synthetic opioids 43.3

systematic review P340, P596

systems neuroscience P478, P665, 43.3

Tac2 42.4

Tacr1 21.1

tACS P449

Tail of the Striatum P473, 38.1

tandem repeat variation P743

task fMRI P11

Task-based fMRI P147, P296, P410

task-based functional connectivity P313, P776

tau P483, P485, 37.5

TBI 31.4

TCF4 P134

TDCS P165

Technology P153

Teen and Young Adult P432

Telemedicine P153

Temporal discrimination P109

Teneurin-4 P501

testosterone P4

tetrahydrocannabinol P642

thalamic subregional connectivity P226

Thalamus P226, P681, P810

THC P152

theory of mind P752, 56.3

Therapeutic Development P595

therapeutic drug monitoring P803

therapeutics 42.2

theta band oscillatory measures P116, P582, P777

theta burst transcranial magnetic stimulation P582

Theta-burst stimulation P571, P588, 27.2

Threat Conditioning P683

Threat imminence continuum theory P79

Threat neurocircuitry P479, P590, 38.1

threat processing P478, 38, 38.4

Threat reactivity 6.4

Tic disorders P445

time-frequency analysis P777

timing 54.2

Tirzepatide P150, 10.2

TLR7 P564

TMS P191, P403, P567, P571, P680, P755, P792, 27.3, 40

TMS targeting P584

TMS-EEG 40.4

TNFa P562

tobacco use disorde 40.2

tolcapone P535

Tolerability P248

Top down regulation P289

top-down control 38

Topiramate P600

Touchscreen cognitive testing P495, P673

Tourette syndrome P445

Transcend Therapeutics P692

transcranial alternating current stimulation P289

transcranial magnetic stimulation P581, P583, P592

transcranial magnetic stimulation (TMS) P296, P302, P584,

P585, P590, P233, P547

transcranial photobiomodulation P527

transcript isoforms 50.3

transcription factors P337

Transcriptome P393

transcriptome biology P199

Transcriptomics P193, P350, P384, P705, P817, 18

Transdermal Estradiol P683

Transdiagnostic P822, 57

Transformer 14.2

transgenerational transmission P284

translational Alzheimer's Disease P483

Translational Animal Models 41, 42.3

Translational biomarker approaches to drug development P105, 45, 45.4

Translational Cognitive Testing P670, P828

Translational Neuroscience P166, 33, 1, 48.3, 49

translational psychiatry P614

Translational research P481, P596, 10, 42, 53

Translational studies P75

translocator protein (TSPO) P850

TRAP2 mice P78, P842

trascriptomic profile P835

trauma P448

Trauma exposure P702

Traumatic Brain Injury P39

TRD P267

treatment P198

Treatment Acceptability P299

Treatment moderators P197

Treatment Resistant Depression P93, P561, P568, P675, 23.3

Treatment resistant schizophrenia P746, P751, 28.2

Treatment response 32.3

Treatment transition P769

treatment-resistant depression P260, 51, 51.1, 51.2, P83,

P121, P228, P232, P241, P264, P587, P660, P217

treatment-resistant Major Depressive Disorder P223

treatment-resistant schizophrenia P758, P774

treatment-resistant-depression P163, P199

Treatment-Response P529

Triazole P610

Tryptophan depletion P234

TSND-201 P692

tumor necrosis factor 29.5

tumor necrosis factor super family P795

twins P282

Two-photon P389

ubiquitin proteasome system P388

Ultra-processed foods P517

Ultra-treatment resistant schizophrenia P746

uncertainty P439

Unsupervised Cognitive Testing P278

vagus nerve P90

vagus nerve stimulation P260, P587

valbenazine P523, P753

valence P834, P839

validation P196

value-based decision making P266

Value-based Decision-Making P320, P322, P729

vaping P368

Vapor P386

variability in brain activity pattern 20.3

vasoactive intestinal peptide P623

Vasopressin 1b antagonist P247

Venlafaxine P213

ventral hippocampus 6.3, P25, P62, P64, P672

Ventral Pallidum P77, P356, P730, 18, 19.2

ventral striatum P188

Ventral Tegmenal Area 30.3

Ventral Tegmental Area P477

Ventral Tegmental Area (VTA) 19.4, 19.5, 30.2, P434, P451, P513, P836

veterans P585, P643, P650, P695, P853

VGLUT3 P69

Vicarious defeat stress P724

violence P30

virtual reality P593, P695

Visual Attention P552

visual contrast sensitivity P756

visual cor P689

visual cortex P689, P702

Visual plasticity P655

Visual Processing 45.2

Visual threat detection P65, P478, P586, 38.2

VMAT2 P243, P753

VTA 19, 19.2

Vulnerability Traits P772

Wearable EEG P773

wearable technology P203, 32.2

Weight loss treatment P323

wheel running P734

white matter P51

white-matter tract P494

Whole exome sequencing P446

whole genome sequencing P743, P766

Whole-Brain Rodent Imaging P398, P512

Wistar Kyoto rat P274

women P18

Women’s Health P866

women's health P863

Women's Mental Health P257, P696, P716, P440

working memory P522, P535, P576, P778, 37.2

working memory fMRI P170, P784

Worry P59, P66

X chromosome P871

xanomeline P156, P603, P757, P766, P767, P769, P872

Youth P118, P868, P54, P119

youth and young adults P279, P282

youth depression P216, P583

zebrafish P50, P500

ZIP8 P333

β-arrestin P138